Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABAA receptor complex

被引:73
作者
Marder, M
Estiú, G
Blanch, LB
Viola, H
Wasowski, C
Medina, JH
Paladini, AC
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina
[2] Natl Univ La Plata, Fac Ciencias Exactas, Dept Quim, CEQUINOR, RA-1900 La Plata, Argentina
[3] Natl Univ La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Div Farm, RA-1900 La Plata, Argentina
[4] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencias, RA-1121 Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0968-0896(00)00250-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A large number of structurally different classes of ligands, many of them sharing the main characteristics of the benzodiazepine (BDZ) nucleus, are active in the modulation of anxiety, sedation, convulsion, myorelaxation, hypnotic and amnesic states in mammals. These compounds have high affinity for the benzodiazepine binding site (BDZ-bs) of the GABA(A) receptor complex. Since 1989 onwards our laboratories established that some natural flavonoids were ligands for the BDZ-bs which exhibit medium to high affinity in vitro and anxiolytic activity in vivo. Further research resulted in the production of synthetic flavonoid derivatives with increased biochemical and pharmacological activities. The currently accepted receptor/pharmacophore model of the BDZ-bs (Zhang, W.; Koeler, K. F.; Zhang, P.; Cook, J. M. Drug Des. Dev. 1995, 12, 193) accounts for the general requirements that should be met by this receptor for ligand recognition. In this paper we present a model pharmacophore which defines the characteristics for a ligand to be able to interact and bind to a flavone site, in the GABA(A) receptor, closely related to the BDZ-bs. A model of a flavone binding site has already been described (Dekermendjian, K.: Kahnberg, P.: Witt, M. R.: Sterner, O.: Nielsen, M.: Liljerfors, T. J. Med. Chem. 1999, 42, 4343). However, this alternative model is based only on graphic superposition techniques using as template a non-BDZ agonist. In this investigation all the natural and synthetic flavonoids found to be ligands for the BDZ-bs have been compared with the classical BDZ diazepam. A QSAR regression analysis of the parameters that describe the interaction demonstrates the relevance of the electronic effects for the ligand binding, and shows that they are associated with the negatively charged oxygen atom of the carbonyl group of the flavonoids and with the nature of the substituent in position 3'. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 56 条
[1]
Ai JL, 1997, DRUG DEVELOP RES, V41, P99, DOI 10.1002/(SICI)1098-2299(199706)41:2<99::AID-DDR7>3.0.CO
[2]
2-M
[3]
Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors [J].
Atack, JR ;
Smith, AJ ;
Emms, F ;
McKernan, RM .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) :255-262
[4]
Barnard EA, 1998, PHARMACOL REV, V50, P291
[5]
BOREA PA, 1987, MOL PHARMACOL, V31, P334
[6]
ELECTROPHYSIOLOGY OF GABAA AND GABAB RECEPTOR SUBTYPES [J].
BORMANN, J .
TRENDS IN NEUROSCIENCES, 1988, 11 (03) :112-116
[7]
GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[8]
CODDING PW, 1985, MOL PHARMACOL, V28, P178
[9]
Benzodiazepines on trial: A research strategy for their rehabilitation [J].
Costa, E ;
Guidotti, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (05) :192-200
[10]
CRIPPEN GM, 1982, MOL PHARMACOL, V22, P11